GO
Loading...

Ackman: Valeant fit into Pershing investing mold

Wednesday, 23 Apr 2014 | 7:32 AM ET

William Ackman, Pershing Square Capital Management, explains why he decided to team up with Valeant Pharmaceuticals to make a play for Allergan.